November 28, 2024 - Topline results PTC Therapeutics cardinALS trial Submitted by wim@als.be on Thu, 11/28/2024 - 09:00
October 15, 2024 - uniQure announces dosing first patient in Phase I-II clinical trial of AMT-162 for SOD1-ALS Submitted by wim@als.be on Tue, 10/15/2024 - 14:59
September 5, 2024 - Decoding regulatory agency decisions - The case of Amylyx's Relyvrio-Albrioza in the US and EU Submitted by wim@als.be on Thu, 09/05/2024 - 09:55
EUpALS awarenes campaign june 21 2024 - 10 years Ice Bucket Challenge Submitted by wim@als.be on Fri, 06/21/2024 - 09:24
EMA announcement positive CHMP opinion for Biogen Tofersen (Qualsody) Submitted by wim@als.be on Fri, 02/23/2024 - 13:02
Januari 23, 2024 - Prilenia Announces Clinical Data in Support of its Plans to Initiate Global Phase 3 Study in ALS Submitted by wim@als.be on Tue, 01/23/2024 - 15:38
